Human schistosomiasis—or bilharzia—is a parasitic disease caused by trematode flukes of
the genus Schistosoma. By conservative estimates, at least 230 million people worldwide …

There is a wealth of immunologic studies that have been carried out in experimental and
human schistosomiasis that can be classified into three main areas: immunopathogenesis …

Over the past few decades, nucleic acid-based methods have been developed for the
diagnosis of intestinal parasitic infections. Advantages of nucleic acid-based methods are …

Background Elimination of schistosomiasis as a public health problem and interruption of
transmission in selected areas are key goals of the World Health Organization for 2025 …

Schistosomiasis is a debilitating disease affecting over 200 million people, with the highest
burden of morbidity and mortality in African countries. Despite its huge impact on the health …

Schistosomiasis affects over 200 million people worldwide, most of whom are children.
Research and control strategies directed at preschool-aged children (PSAC), ie,≤ 5 years …

Schistosomiasis is the second most devastating parasite prevalent in the tropical region of
the world, posing significant public health impacts in endemic areas. Presently, several …

Parasitological detection of Schistosoma is the cornerstone of schistosomiasis diagnosis in
areas of transmission worldwide. However, a steep decrease of sensitivity in low-endemicity …

Background The diagnosis of schistosomiasis currently relies on microscopic detection of
schistosome eggs in stool or urine samples and serological assays. The poor sensitivity of …

Background Urine filtration and microhaematuria reagent strips are basic standard
diagnostic methods to detect urogenital schistosomiasis. We assessed their accuracy for the …